The mechanisms whereby insulin regulates metabolic functions in target tissues are unknown. In particular, the intracellular signaling system that mediates the insulin effect of glucose transport has not been defined. Many recent findings suggest that the diacylglycerol-C-kinase signaling system could play an important role during insulin-induced increases in glucose transport and other metabolic functions. To summarize these findings: (a) insulin stimulates phospholipid metabolism, diacylglycerol generation and activation of C-kinase; (b) C-kinase activation (by various means) provokes insulin-like effects on glucose transport, amino acid transport and pyruvate dehydrogenase activation; and (c) the glucose transporter is phosphorylated by C-kinase. The present research proposal will study further the hypothesis that the diacylglycerol-C-kinase signaling system serves as an intracellular mediator for insulin effects on glucose transport and other metabolic processes. In particular, we will determine (a) how insulin increases diacylglycerol content; (b) how insulin increases C-kinase activity; (c) target tissues wherein insulin increases diacylglycerol and C- kinase; and (d) the more important consequences of insulin- induced increases in diacylglycerol and C-kinase.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK038079-01A1
Application #
3237237
Study Section
Metabolism Study Section (MET)
Project Start
1987-08-01
Project End
1990-07-31
Budget Start
1987-08-01
Budget End
1988-07-31
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of South Florida
Department
Type
Schools of Medicine
DUNS #
City
Tampa
State
FL
Country
United States
Zip Code
33612
Sajan, Mini P; Nimal, Sonali; Mastorides, Stephen et al. (2012) Correction of metabolic abnormalities in a rodent model of obesity, metabolic syndrome, and type 2 diabetes mellitus by inhibitors of hepatic protein kinase C-?. Metabolism 61:459-69
Ortmeyer, Heidi K; Sajan, Mini P; Miura, Atsushi et al. (2011) Insulin signaling and insulin sensitizing in muscle and liver of obese monkeys: peroxisome proliferator-activated receptor gamma agonist improves defective activation of atypical protein kinase C. Antioxid Redox Signal 14:207-19
Sajan, M P; Bandyopadhyay, G; Miura, A et al. (2010) AICAR and metformin, but not exercise, increase muscle glucose transport through AMPK-, ERK-, and PDK1-dependent activation of atypical PKC. Am J Physiol Endocrinol Metab 298:E179-92
Farese, Robert V; Sajan, Mini P (2010) Metabolic functions of atypical protein kinase C: ""good"" and ""bad"" as defined by nutritional status. Am J Physiol Endocrinol Metab 298:E385-94
Sajan, M P; Standaert, M L; Rivas, J et al. (2009) Role of atypical protein kinase C in activation of sterol regulatory element binding protein-1c and nuclear factor kappa B (NFkappaB) in liver of rodents used as a model of diabetes, and relationships to hyperlipidaemia and insulin resistance. Diabetologia 52:1197-207
Sajan, Mini P; Standaert, Mary L; Nimal, Sonali et al. (2009) The critical role of atypical protein kinase C in activating hepatic SREBP-1c and NFkappaB in obesity. J Lipid Res 50:1133-45
Temofonte, N; Sajan, M P; Nimal, S et al. (2009) Combined thiazolidinedione-metformin treatment synergistically improves insulin signalling to insulin receptor substrate-1-dependent phosphatidylinositol 3-kinase, atypical protein kinase C and protein kinase B/Akt in human diabetic muscle. Diabetologia 52:60-4
Farese, Robert V; Sajan, Mini P; Yang, Hong et al. (2007) Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes. J Clin Invest 117:2289-301
Casaubon, L; Sajan, M P; Rivas, J et al. (2006) Contrasting insulin dose-dependent defects in activation of atypical protein kinase C and protein kinase B/Akt in muscles of obese diabetic humans. Diabetologia 49:3000-8
Luna, V; Casauban, L; Sajan, M P et al. (2006) Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects. Diabetologia 49:375-82

Showing the most recent 10 out of 92 publications